Skip to main content

Commercial Litigation Partner Chalon Clark Joins Hunton in Dallas

Chalon Clark, Partner, HuntonChalon Clark, Partner, HuntonDALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) — Nationally recognized litigator Chalon N. Clark has joined Hunton Andrews Kurth LLP in Dallas as a partner in the firm’s commercial litigation practice. Drawing on nearly two decades of experience handling complex, high-value matters, Clark’s practice focuses on high-stakes disputes across the commercial lending, construction, real estate, financial services, products liability, and employment sectors. Clark joins the firm from Husch Blackwell, LLP, where she regularly represented clients before state and federal courts and advised companies on appeals, contract and commercial lease disputes, foreclosures, fraud, and trade secret and noncompete litigation. “Chalon is an outstanding and accomplished trial lawyer whose addition...

Continue reading

SIVP: LUXEED’s Answer to Intelligent Parking in Every Scenario

WUHU, China, Oct. 19, 2026 (GLOBE NEWSWIRE) — Chery Group’s LUXEED Global Media Test Drive concluded on October 20 with a live demonstration of Super Intelligent Valet Parking (SIVP), which impressed participating media with its ability to navigate complex parking environments. The demonstration showcased how LUXEED’s intelligent parking technology handles a range of challenging scenarios, from autonomous parking to vehicle summoning.Built on environmental perception, local path planning and vehicle motion control, SIVP enables LUXEED vehicles to navigate parking facilities at low speeds, detect and avoid obstacles, identify available parking spaces, search for spaces autonomously and execute parking maneuvers without driver intervention. The system also supports remote vehicle summoning via a mobile device, allowing the vehicle...

Continue reading

CSPi Technology Solutions Announces Technology Project

CSPi to deliver Vital™ Managed IT Services, wireless infrastructure, and network project MIAMI, Oct. 19, 2026 (GLOBE NEWSWIRE) — The Miami HEAT today announced a new technology project supported in part by CSPi Technology Solutions, a trusted provider of IT infrastructure and professional technology services. Under the agreement, Kaseya Center Wi-Fi will be powered by AT&T, delivered by AT&T, CSPi and Hewlett Packard Enterprise as CSPi supplies Vital™ Managed IT Services, wireless infrastructure, and a comprehensive network project to support the organization’s technology operations.  The project brings CSPi’s enterprise-grade managed services capabilities and deep networking expertise to the HEAT, ensuring the technology environment is reliable and positioned to scale.  “CSPI didn’t...

Continue reading

Exyn Technologies Interim CEO Ben Williams to Appear Today on FOX Business Network’s “Varney & Company” at Approximately 9:50 a.m. ET

Williams to Discuss Exyn’s Physical AI Technology, Defense Applications and Participation in a U.S. Department of Energy Initiative to Advance Domestic Critical Mineral Discovery PHILADELPHIA, PA, Oct. 19, 2026 (GLOBE NEWSWIRE) — Exyn Technologies (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in physical AI for autonomous mapping and perception-driven navigation in complex, GPS-denied environments, today announced that Ben Williams, Interim Chief Executive Officer and Chief Operating Officer, will appear live today on FOX Business Network’s Varney & Company at approximately 9:50 a.m. Eastern Time. During the interview, Mr. Williams is expected to discuss Exyn’s physical AI technology, ExynAI®, and its growing applications across defense and national security, as well as the Company’s participation, announced...

Continue reading

WeTouch Partners with Hefei Aoweixun to Enter China’s Projected RMB 30 Trillion Silver Economy Through AI Robotics

Strategic cooperation combines WeTouch’s advanced touch technology with Aoweixun’s robotics expertise; Aoweixun is an established supplier to one of China’s top robotics companies, supporting the development of AI-powered elderly care robots and new revenue opportunities. CHENGDU, China, Oct. 19, 2026 (GLOBE NEWSWIRE) — WeTouch Technology Inc. (NASDAQ: WETH) (“WeTouch” or the “Company”), a developer and manufacturer of advanced touch display solutions, today announced that it has entered into a strategic cooperation agreement with Hefei Aoweixun Electronic Technology Co., Ltd. (“Aoweixun”), a China-based robotics technology company and an established supplier to one of China’s top robotics companies, to jointly develop next-generation touch sensing, human-machine interaction...

Continue reading

Straight Talk Supercharges Unlimited Plans with More Data, Faster 5G and Expanded Benefits

Our best plans, now working harder for you: Straight Talk delivers more value across its Silver Unlimited, Gold Unlimited, and Platinum Unlimited Plans—plus Home Internet bundle savings—without raising monthly plan base pricesNEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) — Straight Talk Wireless, available exclusively at Walmart and online, today announced it is supercharging its unlimited plans, including its Silver Unlimited, Gold Unlimited, and Platinum Unlimited Plans. Designed to solidify its position as the value leader for value-driven consumers, Straight Talk is bringing faster 5G Ultra Wideband network access, up to 66% more hotspot data, expanded international coverage, and Home Internet bundle savings across its popular lineup. For Silver Unlimited customers, that means keeping the same $45 monthly base price Straight Talk...

Continue reading

Leads Biolabs’ Opamtistomig and LBL-034 Featured in Six Abstracts at 2026 ESMO Congress

Three Studies Selected for Oral Presentation, Including a Late-Breaking Abstract; Data Highlight Durable Responses and Long-Term Survival Signals Across Immunologically Cold Tumors and Deep, Sustained Responses in Multiple Myeloma NANJING, China, Oct. 19, 2026 (GLOBE NEWSWIRE) — Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that full abstracts from six studies of opamtistomig (LBL-024), its PD-L1/4-1BB bispecific antibody, and LBL-034, its GPRC5D/CD3 bispecific T-cell engager (TCE), have been published on the official website of the 2026 Annual Meeting of the European Society for Medical Oncology (ESMO). The abstracts span clinical trials, translational research and meta-analyses. The data show durable responses and long-tail survival signals with...

Continue reading

FOXO TECHNOLOGIES INC.’S SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC., ANNOUNCES EXPANSION OF ITS FLAGSHIP FACILITY AND FOCUS ON SUBSTANCE USE DISORDER PATIENTS WITH RELATED MEDICAL CARE NEEDS

WEST PALM BEACH, FL, Oct. 19, 2026 (GLOBE NEWSWIRE) — FOXO Technologies Inc.’s (OTC: FOXO) (“FOXO”) is pleased to announce that its subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”), recently received its license from Tennessee Department of Mental Health and Substance Abuse Services to allow it to expand its flagship facility in Oneida, Tennessee from 30 beds to 32 beds (consisting of 16 residential beds and 16 detox beds). In addition, the facility, more recently, has expanded its patient care focus to include patients with medical care needs in addition to substance use disorder care needs. Myrtle is able to offer a wide range of services to these patients, in part, based on its close relationship with its host hospital, Big South Fork Medical Center, an affiliate of Myrtle. Since inception in September 2023, Myrtle has admitted...

Continue reading

Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy

Inside InformationPhase 3 trial with ACARIZAX® in Chinese participants met the primary objective and showed efficacy in line with previous trials, after only 24-28 weeks of treatment. ACARIZAX® was shown to be safe and well-tolerated, consistent with data obtained in previous trials over the past 10+ years. ALK will now work with its partner GenSci to file for regulatory approval of ACARIZAX® in China. Filing is expected in first half of 2027.ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced positive topline results from the phase 3 bridging trial evaluating the efficacy and safety of its house dust mite (‘HDM’) sublingual immunotherapy (‘SLIT’) tablet, ACARIZAX®, in Chinese participants aged 12 – 65 years with HDM allergic rhinitis/rhinoconjunctivitis, with or without asthma. The trial was designed to show a consistent...

Continue reading

Standard Dental Labs Signs $10 Million Equity Purchase Agreement with Twenty Four Capital

Facility gives the Company discretion to access equity capital over time to support its Florida dental laboratory strategy ORLANDO, Fla., Oct. 19, 2026 (GLOBE NEWSWIRE) — Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”), after several weeks of negotiation, today announced that it finalized its common stock purchase agreement with Twenty Four Capital LLC over the weekend. The agreement provides for the potential sale of up to $10 million of SDL common stock, subject to its terms and conditions. The facility is designed to give SDL discretion over when to request purchases and how much capital to seek, within the agreement’s limits. Twenty Four Capital is obligated to purchase shares under a qualifying purchase notice, subject to the applicable conditions. SDL is not required to sell any shares. The $10 million figure...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.